Today, Wade Brewer, CEO & Co-Founder of VENSEARCH, sits down with Severence MacLaughlin, Ph.D., Founder & CEO of DeLorean Artificial Intelligence, to discuss the groundbreaking innovations DeLorean AI is bringing to healthcare. Learn how biologically validated AI is improving patient outcomes, lowering healthcare costs, and transforming the future of personalized medicine.
Timestamps:
00:00 – Introduction
00:19 – Meet Severence MacLaughlin, Ph.D., Founder of DeLorean AI
00:56 – Severence's background and journey in AI and healthcare
01:53 – The founding story of DeLorean AI and its mission
02:49 – DeLorean AI’s breakthrough: Biologically validated AI
03:45 – Disease modules covered by DeLorean AI (Kidney, Cardiac, Diabetes, COPD, Mental Health)
04:54 – How DeLorean AI predicts and prevents adverse events
05:46 – The moral obligation behind healthcare AI innovation
07:00 – Proactive vs Reactive AI in healthcare
07:47 – DeLorean AI's real-world impact: Accuracy stats and patient outcomes
09:24 – Cost savings in healthcare driven by AI predictions
10:42 – Summarizing the double win: Saving lives and lowering costs
11:20 – Challenges in healthcare AI adoption: Buy vs Build debate
12:25 – How DeLorean AI accelerates results and cuts costs for healthcare systems
12:55 – Differentiators: Why DeLorean AI stands out in a crowded AI market
13:30 – Closing thoughts and future vision